Medicare Enrolled
Dr. Worood Abboud, M.D.
Hematology & Oncology · Joliet, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Abboud from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Abboud?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Abboud
Dr. Worood Abboud is a hematology & oncology specialist in Joliet, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Abboud performed 21,277 Medicare services across 2,064 unique beneficiaries.
Between the years covered by Open Payments, Dr. Abboud received a total of $12,458 from 93 pharmaceutical and/or device companies across 597 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Abboud is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 29% volume in IL
$12,458 industry payments
Medicare Practice Summary
Medicare Utilization ↗21,277
Medicare services
Top 29% in IL for hematology & oncology
2,064
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,120 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
10,710 | $0 | $3 |
| Denosumab injection (Prolia/Xgeva) | 3,840 | $18 | $27 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
1,400 | $6 | $22 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
771 | $8 | $40 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
690 | $0 | $1 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
590 | $8 | $20 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
535 | $10 | $55 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
469 | $93 | $229 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
326 | $65 | $151 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
183 | $97 | $218 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
178 | $139 | $307 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
173 | $13 | $54 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
170 | $13 | $70 |
| Iron level test | 159 | $6 | $33 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
159 | $9 | $45 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
140 | $11 | $62 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
83 | $109 | $380 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
61 | $143 | $431 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
59 | $15 | $77 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
58 | $107 | $295 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
57 | $52 | $201 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
57 | $26 | $95 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
51 | $1 | $15 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
50 | $1 | $3 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
45 | $4 | $20 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
40 | $4 | $18 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
40 | $6 | $33 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
37 | $14 | $77 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
31 | $19 | $97 |
| New patient office visit, complex (60-74 min) | 30 | $179 | $443 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
28 | $7 | $34 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
16 | $26 | $105 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
15 | $5 | $25 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
15 | $4 | $21 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
11 | $118 | $359 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
51.0% high complexity
30.1% medium
18.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,458
Total received (2018-2024)
Avg $1,780/year across 7 years
Top 28% in IL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
93
Companies
597
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,413 (83.6%)
Other
Charitable contributions, space rental, and other categories
$1,625 (13.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$420 (3.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,484
2023
$1,311
2022
$1,356
2021
$3,254
2020
$1,171
2019
$1,502
2018
$1,380
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$282
Novartis Pharmaceuticals Corporation
$216
Kedrion Biopharma, Inc.
$170
AstraZeneca Pharmaceuticals LP
$167
Janssen Biotech, Inc.
$165
ABBVIE INC.
$155
Daiichi Sankyo Inc.
$117
Merck Sharp & Dohme LLC
$92
Takeda Pharmaceuticals U.S.A., Inc.
$83
Incyte Corporation
$71
Regeneron Healthcare Solutions, Inc.
$70
Gilead Sciences, Inc.
$64
BeiGene USA, Inc.
$63
Genentech USA, Inc.
$63
Eisai Inc.
$62
Mirati Therapeutics, Inc.
$58
EMD Serono, Inc.
$52
Astellas Pharma US Inc
$49
GlaxoSmithKline, LLC.
$49
Lilly USA, LLC
$48
TerSera Therapeutics LLC
$46
Ipsen Biopharmaceuticals, Inc
$35
E.R. Squibb & Sons, L.L.C.
$33
SpringWorks Therapeutics, Inc.
$28
SOBI, INC
$27
Spectrum Pharmaceuticals Inc.
$25
TAIHO ONCOLOGY, INC.
$22
Invivyd Inc
$21
Dendreon Pharmaceuticals LLC
$20
Immunocore Limited
$20
SERVIER PHARMACEUTICALS LLC
$19
Alexion Pharmaceuticals, Inc.
$17
ImmunoGen, Inc.
$17
PUMA BIOTECHNOLOGY, INC.
$16
Amneal Pharmaceuticals LLC
$16
Tempus AI, Inc
$15
Fennec Pharmaceuticals, Inc.
$13
Top 3 companies account for 26.9% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,978
E.R. Squibb & Sons, L.L.C.
$841
AstraZeneca Pharmaceuticals LP
$563
Lilly USA, LLC
$541
Janssen Biotech, Inc.
$519
Merck Sharp & Dohme Corporation
$516
PFIZER INC.
$506
Genentech USA, Inc.
$496
Takeda Pharmaceuticals U.S.A., Inc.
$299
AbbVie Inc.
$284
Eisai Inc.
$272
Daiichi Sankyo Inc.
$269
GENZYME CORPORATION
$246
TerSera Therapeutics LLC
$229
Global Blood Therapeutics, Inc.
$222
Incyte Corporation
$207
Astellas Pharma US Inc
$205
Amgen Inc.
$198
Pharmacyclics LLC, An AbbVie Company
$187
Seagen Inc.
$177
Celgene Corporation
$172
Kedrion Biopharma, Inc.
$170
NOVARTIS PHARMACEUTICALS CORPORATION
$167
Rigel Pharmaceuticals, Inc.
$159
ABBVIE INC.
$155
Regeneron Healthcare Solutions, Inc.
$140
Bayer HealthCare Pharmaceuticals Inc.
$128
Exelixis Inc.
$126
Gilead Sciences, Inc.
$121
Merck Sharp & Dohme LLC
$109
Pharmacyclics LLC, an AbbVie Company
$102
Ipsen Biopharmaceuticals, Inc
$88
EMD Serono, Inc.
$86
GlaxoSmithKline, LLC.
$86
Janssen Pharmaceuticals, Inc
$86
Myriad Genetic Laboratories, Inc.
$84
BeiGene USA, Inc.
$83
Mirati Therapeutics, Inc.
$80
Dendreon Pharmaceuticals LLC
$73
JAZZ PHARMACEUTICALS INC.
$72
EISAI INC.
$71
TESARO, Inc.
$52
SOBI, INC
$50
Dova Pharmaceuticals
$49
Deciphera Pharmaceuticals Inc.
$49
Karyopharm Therapeutics Inc.
$44
AbbVie, Inc.
$42
Kyowa Kirin, Inc.
$41
TAIHO ONCOLOGY, INC.
$37
Boehringer Ingelheim Pharmaceuticals, Inc.
$37
SERVIER PHARMACEUTICALS LLC
$37
Alexion Pharmaceuticals, Inc.
$35
Cardinal Health 414 LLC
$32
Verastem, Inc.
$32
Puma Biotechnology, Inc.
$32
Alnylam Pharmaceuticals Inc.
$31
Organon LLC
$30
SpringWorks Therapeutics, Inc.
$28
Array BioPharma Inc.
$28
PUMA BIOTECHNOLOGY, INC.
$28
Taiho Oncology, Inc.
$27
Myovant Sciences Inc.
$26
AMAG Pharmaceuticals, Inc.
$25
Helsinn Therapeutics (U.S.), Inc.
$25
Spectrum Pharmaceuticals Inc.
$25
Genmab U.S., Inc.
$24
AVEO Pharmaceuticals, Inc.
$23
Emmaus Medical, Inc.
$23
Novo Nordisk Inc
$23
Jazz Pharmaceuticals Inc.
$22
Agios Pharmaceuticals, Inc.
$21
Innate Pharma, Inc
$21
Invivyd Inc
$21
Foundation Medicine, Inc.
$20
CARDINAL HEALTH 414 LLC
$20
Immunocore Limited
$20
Acceleron Pharma, Inc.
$18
CSL Behring
$18
Aadi Bioscience, Inc.
$18
Blue Earth Diagnostics Limited
$17
Midatech Pharma US Inc
$17
ImmunoGen, Inc.
$17
Verity Pharmaceuticals Inc.
$16
Amneal Pharmaceuticals LLC
$16
Kite Pharma, Inc.
$16
Aveo Pharmaceuticals, Inc.
$15
Pharmacosmos Therapeutics Inc.
$15
Tempus AI, Inc
$15
Acrotech Biopharma LLC
$14
Fennec Pharmaceuticals, Inc.
$13
ADC Therapeutics America, Inc.
$13
Aurobindo Pharma USA, Inc.
$13
Medtronic USA, Inc.
$12
Top 3 companies account for 27.2% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AKYNZEO · ALIMTA · ALUNBRIG · AVASTIN · Abraxane · Albuked · Alecensa · Aliqopa · Avastin · Axumin · BOSULIF · BRUKINSA · Balversa · Bavencio · Blincyto · Braftovi · CABOMETYX · CALQUENCE · CARVYKTI · CHANTIX · CYRAMZA · Cabometyx · Copiktra · DARZALEX · Doptelet · ELAHERE · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Endari · Enhertu · Epkinly · Erleada · FARESTON · FERAHEME · FOTIVDA · FOUNDATIONONE · Fyarro · GAUCHER-DISEASE · GAZYVA · GILOTRIF · GIVLAARI · HEMADY · HYQVIA · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lumoxiti · MEKINIST · MONJUVI · MVASI · MYRISK · Marqibo · Monoferric · NERLYNX · NINLARO · NUCALA · Nerlynx · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONPATTRO · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OSTEOCOOL RF ABLATION · OXBRYTA · Onivyde · PADCEV · PEMAZYRE · PEMGARDA · PIQRAY · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Pedmark · Perjeta · Polivy · Pomalyst · Privigen · QINLOCK · QUZYTTIR · REBLOZYL · ROLVEDON · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · SANCUSO · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SUTENT · Somatuline Depot · Stivarga · TABRECTA · TAFINLAR · TAGRISSO · TASIGNA · TECENTRIQ · TUKYSA · Tavalisse · Tibsovo · Trelstar · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONJO · Vanflyta · Venclexta · Vitrakvi · XARELTO · XERMELO · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · ZEJULA · ZEPZELCA · ZOLADEX · Zoladex · Zuplenz · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (84%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
92
Per 100K population
13.2
County median income
$107,799
Nearest hospital
SAINT JOSEPH MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Abboud is a mixed practice specialist, with above-average Medicare volume (top 29% in IL), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Abboud experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Abboud performed 10,710 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Abboud receive payments from pharmaceutical companies?
Yes. Dr. Abboud received a total of $12,458 from 93 companies across 597 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Abboud's costs compare to other hematology & oncology specialists in Joliet?
Dr. Abboud's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Abboud) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Joliet
Browse hematology & oncology specialists in Joliet ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in IL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in IL
Which IL hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology